3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Carcinoma, Basal Cell
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Psoriasis
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
5
Whole-Body Irradiation
4
Busulfan
4
venetoclax
3
fludarabine phosphate
3
fludarabine
3
Tacrolimus
3
Rituximab
3
Prednisone
3
Methotrexate
3
Inotuzumab Ozogamicin
3
Etoposide
3
Cytarabine
3
Cyclosporine
3
ruxolitinib
2
pegfilgrastim
2
asciminib
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mercaptopurine
2
Filgrastim
2
Dexamethasone
2
Calcium Dobesilate
2
tocilizumab
1
ricolinostat
1
rasburicase
1
ponatinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.